Dow Down0.25% Nasdaq Down0.26%

Nymox Pharmaceutical Corporation (NYMX)

-NasdaqCM
4.95 Down 0.03(0.60%) 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 3,359   3,073   3,114  
Cost of Revenue486  254  290  
Gross Profit 2,873   2,819   2,824  
Operating Expenses
Research Development6,275  8,573  9,461  
Selling General and Administrative1,483  1,841  2,988  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (4,885) (7,595) (9,625)
Income from Continuing Operations
Total Other Income/Expenses Net3  6  13  
Earnings Before Interest And Taxes(4,882)(7,588)(9,613)
Interest Expense27  39  40  
Income Before Tax(4,909)(7,628)(9,652)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(4,909)(7,628)(9,652)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (4,909) (7,628) (9,652)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (4,909) (7,628) (9,652)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.